|
| 32914013 | Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings. | JCO Precis Oncol | 2019 |
| 32914013 | Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings. | JCO Precis Oncol | 2019 |
| 29650751 | FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy. | Clin Cancer Res | 2018 |
| 29473153 | Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. | Int J Cancer | 2018 |
| 29700408 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. | Sci Rep | 2018 |
| 29650751 | FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy. | Clin Cancer Res | 2018 |
| 29700408 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. | Sci Rep | 2018 |
| 29473153 | Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. | Int J Cancer | 2018 |
| 28751443 | FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation-Associated Advanced Ovarian Cancer. | Clin Cancer Res | 2017 |
| 28751443 | FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation-Associated Advanced Ovarian Cancer. | Clin Cancer Res | 2017 |
| 26893016 | Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. | Breast Cancer Res | 2016 |
| 26893016 | Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. | Breast Cancer Res | 2016 |
| 27138982 | Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. | Horm Cancer | 2016 |
| 26645278 | Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. | Cancer Prev Res (Phila) | 2016 |
| 27556229 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. | PLoS One | 2016 |
| 26645278 | Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. | Cancer Prev Res (Phila) | 2016 |
| 27556229 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. | PLoS One | 2016 |
| 27138982 | Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. | Horm Cancer | 2016 |
| 25057183 | A robust association test for detecting genetic variants with heterogeneous effects. | Biostatistics | 2015 |
| 25537643 | Greater absolute risk for all subtypes of breast cancer in the US than Malaysia. | Breast Cancer Res Treat | 2015 |
| 25773928 | Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients. | Breast Cancer Res Treat | 2015 |
| 25516073 | Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults. | Cancer Causes Control | 2015 |
| 25057183 | A robust association test for detecting genetic variants with heterogeneous effects. | Biostatistics | 2015 |
| 25773928 | Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients. | Breast Cancer Res Treat | 2015 |
| 25516073 | Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults. | Cancer Causes Control | 2015 |
| 25537643 | Greater absolute risk for all subtypes of breast cancer in the US than Malaysia. | Breast Cancer Res Treat | 2015 |
| 24292867 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. | Breast Cancer Res Treat | 2014 |
| 24292867 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. | Breast Cancer Res Treat | 2014 |
| 24084887 | Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute. | J Oncol Pract | 2013 |
| 24084887 | Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute. | J Oncol Pract | 2013 |
| 19318476 | Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. | Clin Cancer Res | 2009 |
| 19318476 | Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. | Clin Cancer Res | 2009 |
| 19208741 | Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. | Mol Cancer Res | 2009 |
| 19208741 | Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. | Mol Cancer Res | 2009 |
| 15211573 | Transitions in replication timing in a 340 kb region of human chromosomal R-Band 1p36.1. | J Cell Biochem | 2004 |
| 15211573 | Transitions in replication timing in a 340 kb region of human chromosomal R-Band 1p36.1. | J Cell Biochem | 2004 |